| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1499184A2 Methods and compositions for treating ectoparasite infestation |
| 01/26/2005 | EP1318800B1 1-amino-alkylcyclohexanes as trypanocidal agents |
| 01/26/2005 | EP1107981B1 Synthesis of ring-modified cyclic peptide analogs |
| 01/26/2005 | CN1571780A Synthetic method of 2-(2-nitroethylenyl)-furan and its purpose as anti-coccidium agent |
| 01/26/2005 | CN1571663A Dosage forms, devices and methods of treatment |
| 01/26/2005 | CN1569843A Preparation method for sulfadoxine |
| 01/26/2005 | CN1569020A Folliculitis dermatitis cream |
| 01/26/2005 | CN1186066C Agent for preventing and treating aquatic animal parasitic disease |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/19/2005 | EP1497438A1 Means and methods for the production of adenovirus vectors |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497401A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 01/19/2005 | EP1496934A2 Adjuvant enhanced immunotherapy |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | CN1566129A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 01/19/2005 | CN1565470A Antiparasitic medicine long-acting injection containing |
| 01/19/2005 | CN1565445A N-phenylpyrazoles drug containing long-acting injection for animals |
| 01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/18/2005 | US6844350 Febrifugine, isofebrifugine and method for producing the same |
| 01/18/2005 | US6844012 Suppressing cytokine secretion with such as sodium selenite |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/13/2005 | WO2005002572A2 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/13/2005 | WO2005002570A1 Use of an aziridino compound to selectively inactivate parasites in biological compositions |
| 01/13/2005 | US20050009839 Novel azoles having an insecticidal action |
| 01/13/2005 | US20050009826 5,6,13-trizaza- or 6,13-diazachryseno[2,3-d]-[1,3]dioxole derivatives; enzyme inhibitors; anticarcinogenic, antiproliferative agents; bactericides, fungicides |
| 01/13/2005 | US20050009824 Solubilized topoisomerase poisons |
| 01/13/2005 | US20050008659 Prevention, therapy of Eimeria infections; induction resistance to coccidiosis |
| 01/13/2005 | CA2532066A1 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/12/2005 | EP1496056A1 Novel compounds and antimalarials |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495003A1 Fredericamycin derivatives |
| 01/12/2005 | EP1494718A1 Combination of an agent that attenuates topoisomerase i activity and an agent that inhibits heat shock protein 90 for use in chemotherapy |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494630A2 Bioadhesive drug delivery system |
| 01/12/2005 | EP1244359B1 Combination of fluazuron and ivermectin for parasite control |
| 01/12/2005 | EP1189913B1 Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 01/12/2005 | CN1564809A Organic compounds |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1562149A Fuyanping soft capsule and its preparing method |
| 01/12/2005 | CN1562037A United slow release agent for preventing and treating piglet and rabbit coccidiosis and dysentery and its preparing metod |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184227C Prodn. method of avermectin compounds |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/07/2005 | CA2470768A1 Crystal structure of osc |
| 01/06/2005 | WO2005000348A2 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 01/06/2005 | WO2005000266A2 Liposomal formulations comprising a combination of two or more active agents |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492402A2 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
| 01/05/2005 | EP1031351B1 Leishmaniasis remedy containing glucopyranose derivative as the active ingredient |
| 01/05/2005 | EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 01/05/2005 | CN1561389A Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 01/05/2005 | CN1561230A Antigenic compositions |
| 01/05/2005 | CN1560066A Recombined immune toxin protein of anticryptic sporozoan and its preparation process and medical application |
| 01/05/2005 | CN1559506A Anti-parasite for eel |
| 01/05/2005 | CN1559470A Chinese patent drug for livestock |
| 01/05/2005 | CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former |
| 01/05/2005 | CN1559403A Method for preparing soft capsule prepn. contg. artemisine |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838443 Parasiticides |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838085 DNA immunization against Chlamydia infection |
| 01/04/2005 | CA2139725C Endoparasiticidal compositions |
| 01/04/2005 | CA2106897C Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation |
| 12/30/2004 | US20040267011 Methods for synthesis of diarylmethanes |
| 12/30/2004 | US20040266844 Antimicrobial and radioprotective compounds |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/29/2004 | WO2004113920A1 Screening method for substances binding to merozoite surface protein-1/42 |
| 12/29/2004 | WO2004113310A1 Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| 12/29/2004 | EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 12/29/2004 | EP1490373A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 12/29/2004 | EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 12/29/2004 | EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination |
| 12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
| 12/29/2004 | EP1490037A1 Taste masked veterinary solid compositions |